Alprostadil Container Description: Amber color bottle
Published March 19, 2025 · Recall initiated: February 7, 2025
Summary
FDA records drug Class II recall D-0261-2025, published March 19, 2025 and initiated February 7, 2025. Recalling firm: Aspen Biopharma Labs Pvt., Ltd.; Status: Ongoing; Reported quantity: 3.0 gm; Lot: Lot Numbers: HAALC0020922 exp. date AUG-2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Aspen Biopharma Labs Pvt., Ltd.
- Distributor
- Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)
- Lot
- Lot Numbers: HAALC0020922 exp. date AUG-2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAChlorambucil Container Description: The product packed in double self-seal cover and finally packed inMarch 19, 2025
- FDAFinasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing blackMarch 19, 2025
- FDABimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover and finallyMarch 19, 2025
- FDALatanoprost NDC# 82187-1002-1 Container Description: Amber colour bottleMarch 19, 2025
- FDABD ChloraPrep Clear 1mL Applicators, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA),March 19, 2025
- FDALivalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by: Patheon, Inc. Cincinnati, OHMarch 19, 2025
Questions about this recall
Was Alprostadil Container Description: Amber color bottle recalled?
Yes. FDA published recall D-0261-2025 on March 19, 2025. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · Letter